Arkolith/Insider Trading/HUMA/Form 4

Niklason Laura E

President, CEO and Director, DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Nov 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.6M
Net Open-Market Flow
-$6.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2024Sell(S)261K$4.40$1.2M1.7M
Nov 19, 2024Sell(S)427K$4.34$1.9M2.0M
Nov 18, 2024Sell(S)811K$4.44$3.6M2.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000208) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML